Detailed company information
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Aug 06, 2026
Earnings Transcript for 2026 - Q1Released: May 04, 2026
Earnings Transcript for 2025 - Q4Released: Mar 03, 2026
Earnings Transcript for 2025 - Q3Released: Nov 04, 2025
Earnings Transcript for 2025 - Q2Released: Aug 05, 2025
Earnings Transcript for 2025 - Q1Released: May 07, 2025
Earnings Transcript for 2024 - Q4Released: Mar 04, 2025
Earnings Transcript for 2024 - Q3Released: Nov 09, 2024
Earnings Transcript for 2024 - Q2Released: Aug 06, 2024
Earnings Transcript for 2024 - Q1Released: May 07, 2024
Earnings Transcript for 2023 - Q4Released: Mar 12, 2024
Earnings Transcript for 2023 - Q3Released: Nov 09, 2023
Earnings Transcript for 2023 - Q2Released: Aug 09, 2023
Earnings Transcript for 2023 - Q1Released: May 05, 2023
Earnings Transcript for 2022 - Q4Released: Feb 23, 2023
Earnings Transcript for 2022 - Q3Released: Nov 05, 2022
Earnings Transcript for 2022 - Q2Released: Aug 06, 2022
Earnings Transcript for 2022 - Q1Released: May 07, 2022
Earnings Transcript for 2021 - Q4Released: Feb 24, 2022
Earnings Transcript for 2021 - Q3Released: Nov 04, 2021
Earnings Transcript for 2021 - Q2Released: Aug 08, 2021
Earnings Transcript for 2021 - Q1Released: May 04, 2021
Earnings Transcript for 2020 - Q4Released: Mar 01, 2021
Earnings Transcript for 2020 - Q3Released: Nov 08, 2020
CDNA CareDx, Inc
BLFS BioLife Solutions, Inc.
IRTC iRhythm Technologies, Inc.
NTRA Natera, Inc.
CTKB Cytek Biosciences, Inc.
LFCR Lifecore Biomedical, Inc.
TMO Thermo Fisher Scientific Inc.
CARR Carrier Global Corporation
MXCT MaxCyte, Inc.
XPO XPO Logistics, Inc.
COLD Americold Realty Trust, Inc.
BCRX BioCryst Pharmaceuticals, Inc.
Cryoport anticipates three customer therapy approvals in March/April 2026, projecting modest initial revenue impact with significant ramp-up expected in H2 2026, supporting positive adjusted EBITDA. This aligns with Cryoport's revenue guidance and strategic commercial growth outlook for 2026.
Read post
Dafinchi